KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Guardant Health (GH) EBT (2017 - 2026)

Guardant Health's EBT history spans 9 years, with the latest figure at -$130.2 million for Q4 2025.

  • On a quarterly basis, EBT fell 18.07% to -$130.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$417.5 million, a 4.03% increase, with the full-year FY2025 number at -$417.5 million, up 4.03% from a year prior.
  • EBT hit -$130.2 million in Q4 2025 for Guardant Health, down from -$92.6 million in the prior quarter.
  • Over the last five years, EBT for GH hit a ceiling of -$72.3 million in Q2 2023 and a floor of -$229.0 million in Q2 2022.
  • Historically, EBT has averaged -$118.5 million across 5 years, with a median of -$107.6 million in 2021.
  • Biggest five-year swings in EBT: plummeted 237.1% in 2021 and later soared 68.44% in 2023.
  • Tracing GH's EBT over 5 years: stood at -$72.3 million in 2021, then tumbled by 92.71% to -$139.3 million in 2022, then crashed by 34.63% to -$187.6 million in 2023, then surged by 41.21% to -$110.3 million in 2024, then fell by 18.07% to -$130.2 million in 2025.
  • Business Quant data shows EBT for GH at -$130.2 million in Q4 2025, -$92.6 million in Q3 2025, and -$99.9 million in Q2 2025.